DF
Diana Fridlyand
Physician · Emory University School of Medicine
Credentials: · ·
History
Childrens Hospital of Georgia

Research
MERTK in cancer therapy: Targeting the receptor tyrosine kinase in tumor cells and the immune system
Review · Pharmacology & Therapeutics · 2020 · 81 citations
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
Neuro-Oncology · 2024 · 43 citations
Case report · BMJ Case Reports · 2018 · 8 citations
- FK
3 papers
- AA
1 paper
- AS
1 paper

1 paper

1 paper

1 paper

1 paper
- BP
1 paper
Clinical trials
- 2023–2031
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)



